I was about to post this but you’ve beaten me to it. Quite normal for high growth companies pitching to investors to use these words. Investor pitching 101, and I’m more than happy for management to be using this rhetoric as they can back it up with last few quarters results.
I can’t find who critiqued the price comments on the product features slide my only comment is that agree it’s not a product feature but absolutely would be a lead call out pitching at a conference like this. It’s semantics; they’re not talking to surgeons here; it’s a simple pitch to investors. Don’t get lost or read into it to much - you’re missing the point here
I was about to post this but you’ve beaten me to it. Quite...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
0.040(1.57%) |
Mkt cap ! $1.781B | |||
| Open | High | Low | Value | Volume |
| $2.56 | $2.59 | $2.53 | $3.881M | 1.517M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10150 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 38947 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |